Leukemia is a type of cancer that results in the body making too many abnormal white blood cells. This uncontrolled production results in an excessive amount of white blood cells that may be immature (acute leukemia) or mature (chronic leukemia). The leukemic cells may not function well to fight infection and may interfere with the production of red blood cells (which carry oxygen) and platelets (which control bleeding).
Normally, white blood cells play an important role in the body’s natural defence system. They target and destroy foreign invaders like viruses and bacteria. White blood cells are made in the marrow (the spongy core) of your bones. Without healthy and functioning white blood cells, the body is at risk of developing severe and sometimes fatal infections.
For most people with leukemia, there’s no way to identify what causes it. In some cases, though, specific risk factors can be identified:
All forms of cancer that can spread within the body (malignant), including leukemia, are thought to be due to genetic abnormalities (mutations). In leukemia, the damage occurs in the bone marrow stem cells. These special cells help to manufacture all the other cells in the blood. With this condition the production of these cells is out of control.
Acute leukemia develops within days to weeks, and large numbers of immature cells called “blasts” build up. These cells can’t function as well as normal white blood cells, so people with acute leukemia are at a higher risk of infection. Because the body is so busy producing “blasts,” it can’t make as many red blood cells or platelets, which can cause anemia and bleeding disorders.
Chronic leukemia, which progresses over the course of months to years, involves overproduction of mature white blood cells that cannot function like normal white blood cells.
There are 4 types of leukemia:
Leukemia either causes a shortage of functioning white blood cells, which can impair the immune system, or a buildup of extra white blood cells.
In acute leukemias the extra white blood cells are mostly immature, whereas in chronic leukemias the white blood cells are mature but still function poorly. In either case, fewer platelets (the type of blood cells that help stop bleeding) are produced, causing excessive bleeding. Minor injuries can result in hard-to-stop bleeding and large bruises. Tiny red spots may appear just under the skin.
Because the immune system isn’t working normally, infections are more frequent. Lymph glands and the spleen may become enlarged, causing pain in the left side of the abdomen.
If abnormal cells accumulate in the brain and spinal cord (as in AML), the symptoms include vomiting and headaches. Occasionally, abnormal cells can accumulate in the skin, causing lumps (chloromas) or skin rashes. A lack of red blood cells causes the skin to look pale. It also results in fatigue and shortness of breath.
Blood and bone marrow are sampled to check the types and numbers of blood cells present. High levels of immature white blood cells (and low red blood cell and platelet counts) indicate acute leukemia.
Special tests such as cytogenetic analysis and flow cytometry can help identify the abnormal cells. Knowing the specific type of leukemia helps the doctor determine the appropriate treatment.
CLL can result in an elevated white blood cell count that can remain stable for years and not require treatment. Often, though, mild treatments are required to keep the total count within a manageable range. In rare cases, more aggressive treatments are needed for changes in the white blood cell count or to treat complications such as anemia.
Doctors commonly treat CML with a class of medication called tyrosine kinase inhibitors. This class is also called targeted molecular therapies and works by interfering with the abnormal cells’ ability to overstimulate production of various types of blood cells. After the treatment, many people with leukemia have no signs of leukemia (also called remission) for short periods of time, and some go into long-term remissions in which abnormal cells are no longer found in their blood.
White blood counts and overall health must be monitored, but sufferers can usually continue with normal activities during the therapy.
More aggressive treatments are used to try to get acute leukemias into remission – the stage where normal levels of blood cells are restored. A combination of different chemotherapy medications is used for this.
During the course of therapy, however, levels of some blood components may fall, causing anemia (a lack of red blood cells) or an increased risk of infections. If the number of red blood cells or platelets gets too low, a blood transfusion might be necessary. People with acute leukemias may need to take antibiotics to fight infections. Side effects of chemotherapy include nausea, vomiting, and hair loss.
Bone marrow transplant is the only cure for CML, but it is rarely used today because of success with the ability of tyrosine kinase inhibitors to act on the Philadelphia chromosome to induce a remission. Bone marrow transplant is more commonly used for AML and ALL when chemotherapy alone has a low chance of resulting in a cure. This treatment depends on an exact match between the donor’s bone marrow and the bone marrow of the person receiving it. Otherwise, the body will recognize the transplanted cells as “foreign” and reject them.
All material copyright MediResource Inc. 1996 – 2019. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Source: www.medbroadcast.com/condition/getcondition/Leukemia